Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

101.61
-0.4650-0.46%
Post-market: 101.55-0.0600-0.06%17:10 EDT
Volume:1.09M
Turnover:110.76M
Market Cap:25.52B
PE:-13.07
High:103.00
Open:102.01
Low:100.84
Close:102.08
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.60
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.24
PE(LYR):-18.41

Loading ...

Analysts Offer Insights on Healthcare Companies: Orthofix Medical (OFIX), BioNTech SE (BNTX) and Cogent Biosciences (COGT)

TIPRANKS
·
May 06

BioNTech Slides As Vaccine Sales Drop, Restructuring Plan Takes Shape

Benzinga Earnings
·
May 06

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

TIPRANKS
·
May 05

BioNTech to Shed Jobs, Plants as Covid Vaccine Sales Dwindle -- Update

Dow Jones
·
May 05

Repeat & Correct: BioNTech to Close Sites, Shrink Workforce in Savings Push

Dow Jones
·
May 05

BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. -- Barrons.com

Dow Jones
·
May 05

Biontech SE reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Dow Jones Top Company Headlines at 9 AM ET: Pfizer Posts Better-Than-Expected Revenue, Profit | Coinbase ...

Dow Jones
·
May 05

BioNTech Posts Wider Q1 2026 Operating Loss as R&D Spend Weighs on Results

TIPRANKS
·
May 05

BioNTech Q1 Operating Income EUR -677.5 Million

Reuters
·
May 05

Stock Track | BioNTech Plunges 5.59% in Pre-market on Widening Losses, Site Closures and Job Cuts

Stock Track
·
May 05

GUIDANCE: (BNTX) BioNTech Expects 2026 Revenue Range 2B Euros - 2.3B Euros, vs. FactSet Est of 2.22B Euros

MT Newswires Live
·
May 05

Earnings Flash (BNTX) BioNTech Posts Q1 Adjusted Loss 1.95 Euros a Share

MT Newswires Live
·
May 05

BRIEF-BioNTech To Exit Operations At Curevac's Sites, Sites In Idar-Oberstein, Marburg, Singapore

Reuters
·
May 05

BioNTech Q1 net loss widens to €531.9 million; revenue falls to €118.1 million

Reuters
·
May 05

BioNTech - Confirms 2026 Guidance

THOMSON REUTERS
·
May 05

BioNTech - Expects Recurring Annual Savings of Around EUR 500 Mln Upon Full Implementation of Cost Saving Measures in 2029

THOMSON REUTERS
·
May 05

BioNTech - Exploring Options for Divestments of Each Site, Incl Partial or Total Sale

THOMSON REUTERS
·
May 05

BioNTech - Cost Savings to Support Capital Allocation to Advance Oncology Pipeline Toward Commercialization

THOMSON REUTERS
·
May 05

BioNTech - Plans Share Buyback of American Depositary Shares up to $1 Bln Over Next 12 Mths

THOMSON REUTERS
·
May 05